Clinical Trial to Investigate Efficacy and Safety of the IMP in Patients With Non Healing Wounds Originating From Ulcers

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

January 15, 2019

Study Completion Date

January 15, 2019

Conditions
Skin Ulcer Venous Stasis Chronic
Interventions
BIOLOGICAL

APZ2 application

Application of IMP on patients wound.

Trial Locations (2)

44805

Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken, Kliniken der Ruhr-Universität Bochum im St. Maria-Hilf-Krankenhaus, Bochum

97080

Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie Universitätsklinikum Würzburg, Würzburg

All Listed Sponsors
collaborator

Ticeba GmbH

INDUSTRY

collaborator

FGK Clinical Research GmbH

INDUSTRY

collaborator

Granzer Regulatory Consulting & Services

OTHER

lead

RHEACELL GmbH & Co. KG

INDUSTRY